Posted on Thursday, December 13, 2012 at 4:14 pm CST

Complicated Intra-Abdominal Infections - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Complicated Intra-Abdominal Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Complicated Intra-Abdominal Infections.
Source: Reportstack
Posted on Thursday, December 13, 2012 at 4:15 pm CST

Lung Disease - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Lung Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Lung Disease.
Source: Reportstack
Posted on Thursday, December 13, 2012 at 4:15 pm CST

Primary Sclerosing Cholangitis - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Primary Sclerosing Cholangitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Primary Sclerosing Cholangitis.
Source: Reportstack
Posted on Thursday, December 13, 2012 at 4:16 pm CST

Yellow Fever - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Yellow Fever, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Yellow Fever.
Source: Reportstack
Posted on Thursday, December 13, 2012 at 4:16 pm CST

Post-polycythemia vera myelofibrosis (PPV-MF) - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Post-polycythemia vera myelofibrosis (PPV-MF), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Post-polycythemia vera myelofibrosis (PPV-MF).
Source: Reportstack
Posted on Thursday, December 13, 2012 at 4:17 pm CST

Urea Cycle Disorders - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Urea Cycle Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Urea Cycle Disorders.
Source: Reportstack
Posted on Thursday, December 13, 2012 at 4:17 pm CST

Klebsiella Infections - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Klebsiella Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Klebsiella Infections.
Source: Reportstack
Posted on Thursday, December 13, 2012 at 4:18 pm CST

Chronic Back Pain - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Chronic Back Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Back Pain.
Source: Reportstack
Posted on Thursday, December 13, 2012 at 4:18 pm CST

Klebsiella Pneumoniae Infections - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Klebsiella Pneumoniae Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Klebsiella Pneumoniae Infections.
Source: Reportstack
Posted on Thursday, December 13, 2012 at 4:19 pm CST

Pregnancy - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Pregnancy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pregnancy.
Source: Reportstack
Posted on Thursday, December 13, 2012 at 4:19 pm CST

Schistosomiasis - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Schistosomiasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Schistosomiasis.
Source: Reportstack
Posted on Thursday, December 13, 2012 at 4:21 pm CST

Anal Fistula - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Anal Fistula, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anal Fistula.
Source: Reportstack
Posted on Thursday, December 13, 2012 at 4:22 pm CST

Human Herpesvirus 8 (HHV-8) Infections - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Human Herpesvirus 8 (HHV-8) Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Human Herpesvirus 8 (HHV-8) Infections.
Source: Reportstack
Posted on Thursday, December 13, 2012 at 4:22 pm CST

Meningococcemia (Meningococcal Infections) - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Meningococcemia (Meningococcal Infections), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Meningococcemia (Meningococcal Infections).
Source: Reportstack
Posted on Thursday, December 13, 2012 at 4:04 pm CST
Rolex retailer, Melrose.com has come up with an exclusive collection of luxurious wrist watches. This time, the website has incorporated a few evergreen timepieces from the apex band Cartier. The new product lines introduced by Krishan Agarwal, President of Melrose.com are the ultimate resemblance of elegance and supreme quality. Cartier is a French brand that has been a status symbol since the time it came into existence. The imposing designs and maestro artistry of Cartier watches make them one of the most sought after brand among the watch fanciers.
Source: Melrose
Posted on Thursday, December 13, 2012 at 10:30 pm CST
The new version of partner portal enables easy customization of layouts and visibility of information depending on the role and type of partnership. In addition, actionable reports and dashboards can now be made available to partner users to improve their performance.
Source: crmnext
Posted on Thursday, December 13, 2012 at 10:45 pm CST
CRMnext announces 11 pre-configured vertical editions with best cross domain practices and multidimensional analytics for actionable insights. These include Banking, Insurance, Financial Services, Media, Telecom, Pharmaceutical & Life Sciences, Public Sector, Asset Management, Manufacturing, FMCG, Retail and Automotive.
Source: crmnext
Posted on Friday, December 14, 2012 at 3:30 am CST
Many studies on bicycles have reported that biking is one of the most productive ways of moving, mainly because it is economical, an excellent form of exercise, and great for the environment.
Source: Eleven Eleven Media
Posted on Friday, December 14, 2012 at 3:30 am CST
Winter may not officially start until later this month, but across the UK the signs of the season have already begun. Temperatures have dropped, the chilly weather has arrived, and people are looking for ways to stay cosy and comfortable in their homes.
Source: Eleven Eleven Media
Posted on Friday, December 14, 2012 at 3:00 am CST
Mark Warner Property has introduced it's latest range of properties in Switzerland and is offering a range of houses, apartments, chalets, penthouses, etc. under Swiss property for Sale in the Valais, Verbier and Val D'Anniviers - the regions in Switzerland.
Source: markwarnerproperty
Posted on Friday, December 14, 2012 at 3:15 am CST
It’s not often that a photography studio has over 260 square meters of space to play with, let alone have its own nightclub and cinema hall. However, as unreal as that sounds, that is the studio base for one of the more interesting fashion and modelling agencies in the industry. Not to mention, that the facility, that can only be called a penthouse, is located on the 20th floor of a luxury building in the city of Kiev, Ukraine of all places.
Source: ApplenMicro
Posted on Friday, December 14, 2012 at 3:30 am CST
Dr Oz is one of the United States' most respected medical experts, and subsequently many people will follow his advice whenever he recommends a particular weight loss product.
Source: Jim Woolley
Posted on Friday, December 14, 2012 at 4:15 am CST
A whole trove of rare Beatles memorabilia will be sold at an upcoming auction. The auction, to be held at London’s Bonhams on December 12th, includes a collection of clothing worn by George Harrison which Harrison had gifted to his family over the years.
Source: Eleven Eleven Media
Posted on Friday, December 14, 2012 at 8:30 am CST

GlobalData's clinical trial report, "Ventricular Arrhythmia Global Clinical Trials Review, H2, 2012" provides data on the Ventricular Arrhythmia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Arrhythmia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ventricular Arrhythmia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Source: Fast Market Research
Posted on Friday, December 14, 2012 at 11:23 am CST

Merry Christmas and please pass the antihistamine or inhaler---‘tis the season for asthma and allergies. Like Aunt Helen’s twice re-gifted fruit cake, sneezing and congestion are simply not welcome guests at the family holiday celebration.
Source: GoogleNewsSubmit